Development and validation of highly sensitive and specific LC–MS/MS assays. Low oral doses of selective probe drugs used to phenotype major CYP450 activities. Determination of inter-individual variabilities in major CYP450 activities. Evaluation of drug metabolism CYP450 activities in vulnerable patients.